Molecule Details
InChIKeyJHOZVRGNIYFYHE-UHFFFAOYSA-N
Compound Name2-(5-Hydroxy-naphthalen-1-YL)-1,3-benzooxazol-6-OL
Canonical SMILESOc1ccc2nc(-c3cccc4c(O)cccc34)oc2c1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL7.96
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB07009
Drug Name2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
CAS Numbernan
Groups experimental
ATC Codes nan
Descriptionnan

Cross-references: BindingDB: 50154062 CHEMBL185918 ChemSpider: 20120245 PDB: 338 PubChem:5326827 PubChem:99443480 ZINC: ZINC000003817711
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 8.3 pIC50 TTD_MultiTarget
Q92731 ESR2 Homo sapiens Human PF12497 PF00104 PF00105 8.3 IC50 ChEMBL;BindingDB
P03372 ESR1 Homo sapiens Human PF12743 PF00104 PF02159 PF00105 6.9 IC50 ChEMBL;BindingDB
Q96WX4 erg6 Pneumocystis carinii (strain B80) Pathogen PF08241 PF08498 8.3 pIC50 TTD_MultiTarget
DrugBank Target Actions (3)
Target Gene Target Name Action Type
Q15788 NCOA1 Nuclear receptor coactivator 1 binder targets
Q92731 ESR2 Estrogen receptor beta binder targets
P03372 ESR1 Estrogen receptor inhibitor targets